AdJane is redefining vaccine innovation with its OMV-platform and proprietary adjuvant. Designed to trigger stronger, broader, and longer-lasting immune responses, the platform unlocks new strategies against infectious diseases worldwide. By merging cutting-edge science with entrepreneurship, AdJane addresses today’s most urgent health threats while shaping the vaccines of tomorrow.